A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading
about
Oncolytic Sendai virus-based virotherapy for cancer: recent advancesNyamiviridae: proposal for a new family in the order MononegaviralesAIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding.Paramyxovirus assembly and budding: building particles that transmit infections.Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene.A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.Requirements for the assembly and release of Newcastle disease virus-like particles.Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteinsQuantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein.Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesisGene therapy for cystic fibrosis: an example for lung gene therapy.Correction of Down syndrome and Edwards syndrome aneuploidies in human cell culturesNipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability.RNA replicons - a new approach for influenza virus immunoprophylaxis.Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?Current status of clinical trials assessing oncolytic virus therapy for urological cancers.Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen.Viral and Synthetic RNA Vector Technologies and Applications.The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.The conserved YAGL motif in human metapneumovirus is required for higher-order cellular assemblies of the matrix protein and for virion production.Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein.Generation of a non-transmissive Borna disease virus vector lacking both matrix and glycoprotein genes.Efficient and stable Sendai virus-mediated gene transfer into primate embryonic stem cells with pluripotency preserved.Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils.Production of the virus-like particles of nipah virus matrix protein in Pichia pastoris as diagnostic reagents.Hyaluronic acid pretreatment for Sendai virus-mediated cochlear gene transfer.Reverse genetics identifies the product of open reading frame 4 as an essential particle assembly factor of Nyamanini virus.A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.
P2860
Q26825239-4099B7FF-FE64-40E1-857B-E8EC42CD3946Q30620785-D96F4F8F-3065-4892-A60E-52C1E9F4DF18Q33883865-053D0D0C-579C-4DEC-9048-2142577C57F0Q34020498-75876B1A-B972-4C8F-AA0B-A020A9A9E022Q34183374-F9583C51-832C-497C-9ED3-0916F5517F50Q35076769-6C353688-1CA4-47B7-A8AB-EAF3F8913D97Q35139627-63DFE9B9-1A3D-4D12-840B-6A921BC5E015Q35188142-5D734283-DEE3-4547-BAE1-3377B6C9F248Q35608833-E473CA43-067B-4445-A482-F67ACCCB06DEQ35784833-A9F5906E-CB35-49DE-9336-DA75F65F7304Q35904424-3C3BE8A2-0845-4095-8CFC-25DDA75312E5Q36131210-CCD01D16-D238-4F15-B5DB-EBDD10F28E48Q36736762-BEAA87B8-955B-4064-8A08-BEEBD5956AC9Q37945198-507840D9-4D56-4B51-857C-3339BA667C8FQ38008023-535A9C02-E14A-48E6-9301-448103528AF9Q38741837-782271D6-959D-488C-AF47-11B7DF40BAF4Q38833411-A1F3643B-13BF-42D9-A8DE-B6FF3949AFF1Q38885624-B49F2432-A766-4388-8AF4-84A16E72EC4EQ39399605-C1DB55D1-D076-4941-B0F8-8CA6F9B07BE6Q39400036-43E991A2-9A7A-4280-873F-69F53B49630DQ39551825-C683CFA7-D7A9-4B5F-B810-1ECAFF331023Q40075622-A167D177-D425-4AF0-96F6-9457D9352869Q40094863-3A4FC125-DA6B-470E-849A-7225CD79F076Q40475755-CD97E0F4-FAA4-48E2-9F13-8EE5FFD16899Q40566666-C76C6B45-81BD-4C6E-8B1E-978697B77F88Q40590314-AD4FEF49-09BF-4A8D-A380-FA39F413E8F3Q40794904-DE185CCE-5FF0-4FD3-86CB-75840DA0D118Q41372707-DDC1F132-ECBB-42F5-8314-4F6C81EEC062Q41880392-999780A1-5DC3-4201-9203-3D2F5FDEA7FFQ45607386-3D7EFC1D-69A8-4E0E-90E4-6D3C9E53952D
P2860
A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A new Sendai virus vector defi ...... tensive cell-to-cell spreading
@en
A new Sendai virus vector defi ...... ensive cell-to-cell spreading.
@nl
type
label
A new Sendai virus vector defi ...... tensive cell-to-cell spreading
@en
A new Sendai virus vector defi ...... ensive cell-to-cell spreading.
@nl
prefLabel
A new Sendai virus vector defi ...... tensive cell-to-cell spreading
@en
A new Sendai virus vector defi ...... ensive cell-to-cell spreading.
@nl
P2093
P2860
P1433
P1476
A new Sendai virus vector defi ...... tensive cell-to-cell spreading
@en
P2093
Akihiro Iida
Hiroshi Ban
Makoto Inoue
Mamoru Hasegawa
Masayuki Shirakura
Takahiro Hirata
Takumi Kanaya
Yoshiyuki Nagai
Yumiko Tokusumi
P2860
P304
P356
10.1128/JVI.77.11.6419-6429.2003
P407
P577
2003-06-01T00:00:00Z